Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Silk Road Medical Inc (SILK) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Silk Road Medical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1397702.
Total stock buying since 2019: $302,032.
Total stock sales since 2019: $980,216,589.
Total stock option exercises since 2019: $5,031,538.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 11,700 | $198,782 | 24,426 | $457,142 | 0 | $0 |
| 2023 | 0 | $0 | 284,117 | $14,134,791 | 157,936 | $831,223 |
| 2022 | 0 | $0 | 437,729 | $20,954,806 | 343,843 | $891,733 |
| 2021 | 2,500 | $103,250 | 321,886 | $17,008,010 | 311,690 | $1,707,275 |
| 2020 | 0 | $0 | 10,203,279 | $401,956,751 | 588,370 | $1,009,863 |
| 2019 | 0 | $0 | 14,553,657 | $525,705,089 | 252,580 | $591,444 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-29 | Buchanan Lucas W. (COO/CFO) | Option Ex | 10,000 | 12.15 | 121,500 |
| 2021-03-11 | Rogers Erica J. (President and CEO) | Sale | 11,000 | 52.96 | 582,516 |
| 2021-03-11 | Rogers Erica J. (President and CEO) | Option Ex | 11,000 | 1.60 | 17,600 |
| 2021-03-02 | Rogers Erica J. (President and CEO) | Sale | 1,651 | 56.62 | 93,477 |
| 2021-03-01 | Davis Andrew S. (Chief Commercial Officer) | Sale | 7,472 | 56.49 | 422,123 |
| 2021-03-01 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 7,472 | 1.46 | 10,909 |
| 2021-02-24 | Buchanan Lucas W. (COO/CFO) | Sale | 10,000 | 53.63 | 536,350 |
| 2021-02-24 | Buchanan Lucas W. (COO/CFO) | Option Ex | 10,000 | 8.38 | 83,829 |
| 2021-02-17 | Buchanan Lucas W. (COO/CFO) | Option Ex | 10,000 | 1.60 | 16,000 |
| 2021-02-11 | Rogers Erica J. (President and CEO) | Sale | 11,000 | 59.55 | 655,061 |
| 2021-02-11 | Rogers Erica J. (President and CEO) | Option Ex | 11,000 | 1.60 | 17,600 |
| 2021-02-01 | Davis Andrew S. (Chief Commercial Officer) | Sale | 7,472 | 54.12 | 404,392 |
| 2021-02-01 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 7,472 | 1.46 | 10,909 |
| 2021-01-27 | Buchanan Lucas W. (COO/CFO) | Sale | 10,000 | 54.86 | 548,620 |
| 2021-01-27 | Buchanan Lucas W. (COO/CFO) | Option Ex | 10,000 | 4.73 | 47,300 |
| 2021-01-11 | Rogers Erica J. (President and CEO) | Sale | 11,000 | 59.66 | 656,293 |
| 2021-01-11 | Rogers Erica J. (President and CEO) | Option Ex | 11,000 | 1.60 | 17,600 |
| 2021-01-04 | Davis Andrew S. (Chief Commercial Officer) | Sale | 7,472 | 59.67 | 445,869 |
| 2021-01-04 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 7,472 | 1.46 | 10,909 |
| 2020-12-29 | Buchanan Lucas W. (COO/CFO) | Sale | 10,000 | 60.04 | 600,360 |
| 2020-12-29 | Buchanan Lucas W. (COO/CFO) | Option Ex | 18,000 | 3.17 | 56,970 |
| 2020-12-14 | Buchanan Lucas W. (COO/CFO) | Option Ex | 7,000 | 1.60 | 11,200 |
| 2020-12-11 | Rogers Erica J. (President and CEO) | Sale | 11,000 | 58.35 | 641,872 |
| 2020-12-11 | Rogers Erica J. (President and CEO) | Option Ex | 11,000 | 1.53 | 16,830 |
| 2020-12-11 | Buchanan Lucas W. (COO/CFO) | Option Ex | 7,000 | 1.60 | 11,200 |
| 2020-12-01 | Davis Andrew S. (Chief Commercial Officer) | Sale | 7,472 | 56.63 | 423,109 |
| 2020-12-01 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 7,472 | 1.46 | 10,909 |
| 2020-11-25 | Buchanan Lucas W. (COO/CFO) | Sale | 10,000 | 57.08 | 570,830 |
| 2020-11-25 | Buchanan Lucas W. (COO/CFO) | Option Ex | 10,000 | 4.73 | 47,300 |
| 2020-11-23 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Option Ex | 108,974 | 1.55 | 169,236 |
| 2020-11-17 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Sale | 14,221 | 59.84 | 850,970 |
| 2020-11-17 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Option Ex | 14,221 | 1.42 | 20,193 |
| 2020-11-11 | Rogers Erica J. (President and CEO) | Sale | 11,000 | 63.44 | 697,818 |
| 2020-11-11 | Rogers Erica J. (President and CEO) | Option Ex | 11,000 | 1.46 | 16,060 |
| 2020-11-02 | Davis Andrew S. (Chief Commercial Officer) | Sale | 6,640 | 61.37 | 407,483 |
| 2020-11-02 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 6,640 | 1.46 | 9,694 |
| 2020-10-14 | Buchanan Lucas W. (COO/CFO) | Sale | 9,600 | 65.21 | 626,015 |
| 2020-10-14 | Buchanan Lucas W. (COO/CFO) | Option Ex | 9,600 | 4.73 | 45,408 |
| 2020-10-12 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 66.16 | 1,326,131 |
| 2020-10-12 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.46 | 29,264 |
| 2020-10-01 | Davis Andrew S. (Chief Commercial Officer) | Sale | 6,635 | 65.60 | 435,236 |
| 2020-10-01 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2020-09-17 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 67.32 | 646,281 |
| 2020-09-17 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 4.73 | 45,408 |
| 2020-09-11 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 60.98 | 1,222,343 |
| 2020-09-11 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.41 | 28,201 |
| 2020-09-01 | Davis Andrew S. (Chief Commercial Officer) | Sale | 6,635 | 59.72 | 396,262 |
| 2020-09-01 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2020-08-17 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 53.86 | 517,094 |
| 2020-08-17 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 3.17 | 30,384 |
| 2020-08-11 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 51.42 | 1,030,622 |
| 2020-08-11 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2020-08-03 | Davis Andrew S. (Chief Commercial Officer) | Sale | 6,635 | 47.79 | 317,099 |
| 2020-08-03 | Davis Andrew S. (Chief Commercial Officer) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2020-07-15 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 45.99 | 441,542 |
| 2020-07-15 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 1.60 | 15,360 |
| 2020-07-13 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 45.42 | 910,438 |
| 2020-07-13 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2020-07-01 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 6,635 | 41.95 | 278,344 |
| 2020-07-01 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2020-06-15 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 36.97 | 354,873 |
| 2020-06-15 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 1.60 | 15,360 |
| 2020-06-11 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 37.29 | 747,440 |
| 2020-06-11 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2020-06-01 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 6,635 | 38.67 | 256,601 |
| 2020-06-01 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2020-05-15 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 38.61 | 370,627 |
| 2020-05-15 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 1.60 | 15,360 |
| 2020-05-11 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 37.63 | 754,255 |
| 2020-05-11 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2020-05-05 | Warburg Pincus Partners Gp Llc (10% Owner) | Sale | 4,885,078 | 39.00 | 190,518,042 |
| 2020-05-05 | Warburg Pincus Llc (10% Owner) | Sale | 4,885,078 | 39.00 | 190,518,042 |
| 2020-05-01 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 13,270 | 41.03 | 544,481 |
| 2020-05-01 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 13,270 | 1.46 | 19,374 |
| 2020-04-15 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 19,100 | 33.66 | 643,001 |
| 2020-04-15 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 19,100 | 1.60 | 30,560 |
| 2020-04-14 | Rogers Erica J. (President and CEO) | Sale | 2,744 | 35.00 | 96,040 |
| 2020-04-14 | Rogers Erica J. (President and CEO) | Option Ex | 2,744 | 1.38 | 3,786 |
| 2020-04-13 | Rogers Erica J. (President and CEO) | Sale | 17,300 | 35.02 | 605,811 |
| 2020-04-13 | Rogers Erica J. (President and CEO) | Option Ex | 17,300 | 1.38 | 23,873 |
| 2020-04-01 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 16,273 | 1.53 | 24,897 |
| 2020-03-16 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 100 | 30.25 | 3,025 |
| 2020-03-16 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 100 | 1.60 | 160 |
| 2020-03-11 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 37.37 | 748,944 |
| 2020-03-11 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2020-03-04 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Option Ex | 8,000 | 1.38 | 11,040 |
| 2020-03-02 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 6,635 | 40.33 | 267,589 |
| 2020-03-02 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2020-02-18 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 46.79 | 449,212 |
| 2020-02-18 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 1.60 | 15,360 |
| 2020-02-11 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 47.43 | 950,646 |
| 2020-02-11 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2020-02-03 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 6,635 | 46.70 | 309,881 |
| 2020-02-03 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2020-01-15 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 41.78 | 401,068 |
| 2020-01-15 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 1.60 | 15,360 |
| 2020-01-13 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 40.53 | 812,343 |
| 2020-01-13 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2020-01-02 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 6,635 | 39.94 | 264,981 |
| 2020-01-02 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2019-12-23 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Option Ex | 7,407 | 1.35 | 9,999 |
| 2019-12-18 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Sale | 42,222 | 36.77 | 1,552,714 |
| 2019-12-18 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Option Ex | 32,222 | .68 | 21,910 |
| 2019-12-18 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 7,628 | 4.73 | 36,080 |
| 2019-12-17 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Sale | 10,000 | 36.09 | 360,900 |
| 2019-12-16 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 36.25 | 347,990 |
| 2019-12-16 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 1.60 | 15,360 |
| 2019-12-12 | Rogers Erica J. (President and CEO) | Sale | 18,397 | 35.00 | 643,895 |
| 2019-12-12 | Rogers Erica J. (President and CEO) | Option Ex | 18,397 | 1.38 | 25,387 |
| 2019-12-11 | Rogers Erica J. (President and CEO) | Sale | 1,647 | 35.00 | 57,645 |
| 2019-12-11 | Rogers Erica J. (President and CEO) | Option Ex | 1,647 | 1.38 | 2,272 |
| 2019-12-02 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 6,635 | 35.70 | 236,869 |
| 2019-12-02 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2019-11-26 | Warburg Pincus Partners Gp Llc | Sale | 1,500,000 | 35.00 | 52,500,000 |
| 2019-11-26 | Landy Joseph P. | Sale | 1,500,000 | 35.00 | 52,500,000 |
| 2019-11-25 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Sale | 7,777 | 36.80 | 286,193 |
| 2019-11-22 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Sale | 34,444 | 36.21 | 1,247,320 |
| 2019-11-22 | Ruedy Richard (EVPClin&Reg.Affairs&QA) | Option Ex | 32,222 | .68 | 21,910 |
| 2019-11-20 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Sale | 6,635 | 35.99 | 238,820 |
| 2019-11-20 | Davis Andrew S. (EVPGlobal Sales& Marketing) | Option Ex | 6,635 | 1.46 | 9,687 |
| 2019-11-15 | Buchanan Lucas W. (Chief Financial Officer) | Sale | 9,600 | 37.32 | 358,291 |
| 2019-11-15 | Buchanan Lucas W. (Chief Financial Officer) | Option Ex | 9,600 | 1.60 | 15,360 |
| 2019-11-11 | Rogers Erica J. (President and CEO) | Sale | 20,044 | 35.00 | 701,540 |
| 2019-11-11 | Rogers Erica J. (President and CEO) | Option Ex | 20,044 | 1.38 | 27,660 |
| 2019-08-13 | Warburg Pincus Partners Gp Llc | Sale | 630,000 | 39.50 | 24,885,000 |
| 2019-08-13 | Landy Joseph P. | Sale | 630,000 | 39.50 | 24,885,000 |
| 2019-08-08 | Warburg Pincus Partners Gp Llc | Sale | 4,163,328 | 39.50 | 164,451,456 |
| 2019-08-08 | Landy Joseph P. | Sale | 4,163,328 | 39.50 | 164,451,456 |
| 2019-05-08 | Ruedy Richard (EVP Clin & Reg. Affairs and QA) | Option Ex | 29,999 | 1.60 | 47,998 |
| 2019-04-08 | Warburg Pincus Partners Gp Llc | Sale | 900,000 | 20.00 | 18,000,000 |
| 2019-04-08 | Landy Joseph P. | Sale | 900,000 | 20.00 | 18,000,000 |
| 2019-04-04 | Weatherman Elizabeth H | Option Ex | 70,544 | 4.93 | 348,134 |
Insider trading activities including stock purchases, stock sales, and option exercises of SILK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Silk Road Medical Inc (symbol SILK, CIK number 1397702) see the Securities and Exchange Commission (SEC) website.